ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Personal Finance
    • PPF
    • Mutual Funds
    • Income tax
    • EPFO
    • Income Tax Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • Home Loan Calculator
    • SIP calculator
    • SWP Calculator
    • MF Returns Calculator
    • Lumpsum Calculator
  • India
    • Companies
    • Property
    • Startups
    • Uidai
  • Economy
    • Aviation
  • Tech
    • Mobiles
    • Apps
  • Auto
    • Cars
    • Bikes
  • Markets
    • Commodities
    • Currency
  • Railways
  • World
    • Economy
    • Politics
    • Markets
  • videos
  • photos
  • Bitbns
  • Marksmen 2022
  • More ...
    • VIDEOS
    • PHOTOS
    • MARKSMEN 2022
BREAKING NEWS
  • Common man hit by rising inflation as everyday products become expensive; check what all is getting dearer
  • Brightcom Group bonus share: Company receives Final Trading Approvals for bonus issue from BSE, NSE
  • Dalal Street Corner: After 3 back-to-back weak sessions, indices end higher by 0.5-1% this week; what should investors do?
  • Exclusive: Sebi conducts raids at 30 locations in Maharashtra, Gujarat in Axis Mutual Fund front running case
  • Apple iPhone 14 Pro launch: Multiple color options to ‘i-shaped’ notch - All you need to know
Read in App
Business News » Companies News

Glenmark launches generic version of cholesterol drug Zetia in US market

Glenmark and its partner Endo will be entitled to 180 days of generic drug exclusivity for ezetimibe.

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
Glenmark launches generic version of cholesterol drug Zetia in US market
An illustration of tablets and capsules. Photo: Pixabay

Glenmark Pharmaceuticals Inc., USA, on Monday announced launch of generic version of Zetia in the US market.

"We have launched ezetimibe, the first and only generic version of Zetia (Merck) in the United States for the treatment of high cholesterol," a statement issued here said.

The availability of ezetimibe is the result of a licensing partnership with Par Pharmaceutical, an Endo International plc operating company, with whom Glenmark will share profits.

Glenmark and its partner Endo will be entitled to 180 days of generic drug exclusivity for ezetimibe, it said.

Ezetimibe is indicated as adjunctive therapy to diet for the reduction of elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (Apo B) in patients with primary hyperlipidemia.

According to IMS Health data for the 12-month period ending October 2016, annual US sales of Zetia 10 mg were approximately $2.3 billion.

"Our partnership with Par to bring the first generic version of ZETIA to market only underscores our joint commitment to bridging the gap between patients and the medicines they need most," Glenmark

Pharmaceuticals President of North America and Global API Robert Matsuk said.

"We, along with our partners at Glenmark, are proud to be able to offer patients managing their cholesterol levels the first generic version of Zetia," President of Par Pharmaceutical Tony Pera said.

Glenmark's current portfolio consists of 111 products authorized for distribution in the US marketplace and 64 ANDAs pending approval with the US Food and Drug Administration.

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
Glenmarkgeneric drugsZetiaUS Food and Drug Administration (USFDA)DrugsPharma
Written By: PTI
Updated: Mon, Dec 12, 2016
08:06 pm
Mumbai, PTI
RELATED NEWS
Glenmark Pharma net profit rise 24%; Europe segment major contributor Glenmark Pharma net profit rise 24%; Europe segment major contributor
Sun, Dr Reddy's, Glenmark strengthen their US play Sun, Dr Reddy's, Glenmark strengthen their US play

LATEST NEWS

Stranger Things Season 4 sticker pack available on WhatsApp - Check how to download on Android and iOS

Q4 results 2022: IIFCL, BEML, GAIL India and Ruchi Soya declare March quarter results; here are key highlights!

Brightcom Group bonus share: Company receives Final Trading Approvals for bonus issue from BSE, NSE

Kia EV6: Check launch date, time in India; how to watch LIVE event online, streaming link and other details

iVOOMi Energy to start bookings for e-scooter from May 30; deliveries from mid-June

Paradeep Phosphates IPO makes tepid debut on exchanges; shares list at nearly 5% premium

Q4 Results 2022: Indiabulls Real Estate, Oil India, Arvind Fashions and Realty firm Puravankara declare March quarter results - key highlights

Hindalco: Brokerages see up to 69% upside in this Aditya Birla Group's stock post q4 result - Here is why

Bharat Drone Mahotsav 2022: PM Narendra Modi to inaugurate India's biggest Drone Festival shortly | Direct link to watch live event on YouTube

Exclusive: Sebi conducts raids at 30 locations in Maharashtra, Gujarat in Axis Mutual Fund front running case

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
© 2022. India Dot Com Private Limited. All Rights Reserved.
LIVE TV